Valeo Financial Advisors LLC Grows Position in McKesson Co. (NYSE:MCK)

Valeo Financial Advisors LLC increased its position in McKesson Co. (NYSE:MCK) by 3.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,243 shares of the company’s stock after purchasing an additional 45 shares during the quarter. Valeo Financial Advisors LLC’s holdings in McKesson were worth $575,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in MCK. Fairfield Bush & CO. purchased a new position in shares of McKesson in the 1st quarter valued at approximately $46,000. Synovus Financial Corp lifted its stake in shares of McKesson by 4.0% in the 1st quarter. Synovus Financial Corp now owns 2,192 shares of the company’s stock valued at $673,000 after purchasing an additional 85 shares during the period. Prudential PLC purchased a new position in shares of McKesson in the 1st quarter valued at approximately $1,610,000. Cetera Investment Advisers lifted its stake in shares of McKesson by 17.8% in the 1st quarter. Cetera Investment Advisers now owns 9,839 shares of the company’s stock valued at $3,012,000 after purchasing an additional 1,490 shares during the period. Finally, Moors & Cabot Inc. purchased a new position in shares of McKesson in the 1st quarter valued at approximately $598,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Transactions at McKesson

In related news, CEO Brian S. Tyler sold 3,473 shares of McKesson stock in a transaction on Friday, March 15th. The stock was sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the transaction, the chief executive officer now directly owns 43,445 shares in the company, valued at $22,789,074.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Brian S. Tyler sold 3,473 shares of McKesson stock in a transaction on Friday, March 15th. The stock was sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the transaction, the chief executive officer now directly owns 43,445 shares in the company, valued at $22,789,074.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Leann B. Smith sold 186 shares of McKesson stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the transaction, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The disclosure for this sale can be found here. Company insiders own 0.21% of the company’s stock.

Wall Street Analysts Forecast Growth

MCK has been the subject of a number of analyst reports. Leerink Partnrs reaffirmed an “outperform” rating on shares of McKesson in a research report on Monday, February 26th. UBS Group raised their price objective on McKesson from $575.00 to $620.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Mizuho raised their price objective on McKesson from $450.00 to $505.00 and gave the company a “neutral” rating in a research report on Friday, February 9th. SVB Leerink initiated coverage on McKesson in a research report on Monday, February 26th. They set an “outperform” rating and a $600.00 price objective for the company. Finally, StockNews.com lowered McKesson from a “strong-buy” rating to a “buy” rating in a research report on Thursday, January 4th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $528.64.

McKesson Price Performance

MCK stock opened at $523.01 on Friday. The company has a market cap of $68.73 billion, a P/E ratio of 23.70, a price-to-earnings-growth ratio of 1.42 and a beta of 0.45. McKesson Co. has a 1 year low of $352.34 and a 1 year high of $543.00. The stock’s fifty day moving average price is $523.05 and its 200-day moving average price is $483.69.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, February 7th. The company reported $7.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.05 by $0.69. The firm had revenue of $80.90 billion for the quarter, compared to the consensus estimate of $77.93 billion. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The company’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same period last year, the business posted $6.90 EPS. As a group, analysts expect that McKesson Co. will post 27.59 earnings per share for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Friday, March 1st were paid a $0.62 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $2.48 dividend on an annualized basis and a dividend yield of 0.47%. McKesson’s dividend payout ratio (DPR) is currently 11.24%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.